PUBLISHER: TechSci Research | PRODUCT CODE: 1949565
PUBLISHER: TechSci Research | PRODUCT CODE: 1949565
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The Global Single Use Consumables Market is projected to expand from USD 3.20 Billion in 2025 to USD 4.52 Billion by 2031, reflecting a compound annual growth rate of 5.92%. This market consists of disposable elements, such as bioreactor bags, tubing, connectors, and filtration assemblies, which are used in biopharmaceutical production to substitute conventional stainless-steel apparatus. The industry is primarily driven by the ability to forego complicated sterilization and cleaning validation processes, a benefit that significantly decreases initial capital costs and lowers cross-contamination risks. Additionally, these consumables provide essential manufacturing adaptability, enabling facilities to swiftly alternate between product lines and expedite commercialization schedules.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.20 Billion |
| Market Size 2031 | USD 4.52 Billion |
| CAGR 2026-2031 | 5.92% |
| Fastest Growing Segment | Biopharmaceutical & Pharmaceutical Companies |
| Largest Market | North America |
Despite these operational benefits, the industry encounters significant hurdles regarding environmental sustainability and the handling of solid plastic waste resulting from disposable systems. Stakeholders face mounting pressure to align the efficiency of single-use technologies with corporate carbon reduction targets and waste disposal mandates. According to the Bio-Process Systems Alliance, biopharmaceutical manufacturing-related plastic waste was calculated to constitute less than 0.002% of global plastic waste in 2025, a figure that highlights the complexity involved in formulating appropriate disposal strategies for the industry.
Market Driver
A primary factor accelerating the uptake of single-use consumables is the significant reduction in upfront capital expenditures and ongoing operational costs. Biopharmaceutical manufacturers are increasingly favoring these disposable components over conventional stainless-steel systems to avoid the financial strain associated with complex cleaning and sterilization validation. By transitioning from substantial initial investments in fixed assets to an operating expense model centered on consumables, facilities can greatly improve their financial flexibility and resource distribution. This shift is reflected in the contrast between equipment and consumable sales; while capital equipment investments have struggled, demand for disposable options remains strong. According to Sartorius Stedim Biotech, July 2025, in the 'Half-year results 2025' press release, the firm achieved a 9.4% increase in sales revenue in constant currencies during the first half of the year, a growth trend specifically attributed to high-margin recurring business involving single-use consumables.
Concurrently, the rapid growth of the Contract Development and Manufacturing (CDMO) sector acts as a crucial volume driver for the market. Because CDMOs handle varied client portfolios necessitating unique manufacturing procedures, they rely heavily on single-use technologies to facilitate quick changeovers and reduce cross-contamination risks without the need for lengthy sanitation cycles. This operational versatility enables contract manufacturers to swiftly expand capacity in response to increasing global demand for biologics. According to Lonza, July 2025, in the 'Half-Year Report 2025', its CDMO division generated sales of CHF 3.1 billion for the first six months, marking a 23.1% increase at constant exchange rates. This sector-wide growth is supported by broader industry views on capacity scaling; according to Cytiva, in 2025, 56% of biopharma executives concurred that domestic biologics manufacturing is poised to increase significantly over the coming three years, highlighting the continued need for disposable manufacturing components.
Market Challenge
The environmental sustainability issue concerning the disposal of solid plastic waste serves as a major constraint on the growth of the Global Single Use Consumables Market. As leading biopharmaceutical firms aggressively chase corporate carbon neutrality and net-zero objectives, the dependence on disposable plastic parts presents a direct contradiction to these strategic environmental ambitions. This tension compels manufacturers to reconsider or postpone shifting from stainless steel to single-use frameworks, as the latter unavoidably produces large amounts of bio-contaminated waste that challenges recycling efforts. As a result, the discord between disposable workflows and stringent corporate environmental governance hinders market adoption and adds complexity to procurement strategies.
The growing quantity of waste produced by these systems further exacerbates this constraint by increasing disposal expenses and compliance obligations. According to the International Society for Pharmaceutical Engineering, in 2024, it was reported that plastic waste related to biopharmaceutical manufacturing is anticipated to rise to 11,700 metric tons annually by 2028. This expected growth in waste tonnage creates a substantial liability for manufacturers, leading to hesitation in adopting single-use consumables as stakeholders attempt to reconcile the long-term environmental impact with the operational advantages.
Market Trends
The market is increasingly characterized by the creation of customized solutions for cell and gene therapy (CGT) production, which necessitates specialized, closed-system consumables to ensure sterility. Unlike conventional biologics, CGT processes require modular single-use assemblies that can support patient-specific batches while preventing cross-contamination. This transition requires the redesign of bioreactors and tubing kits to meet the distinct volume and sensitivity needs of viral vector and autologous cell manufacturing. The necessity for such specialized infrastructure is highlighted by recent regulatory achievements; according to the Alliance for Regenerative Medicine, January 2025, in the '2025 Cell & Gene State of the Industry Briefing', the sector secured a record nine regulatory approvals for new cell and gene therapies in 2024, a surge that directly boosts the demand for modality-specific disposable technologies.
At the same time, the incorporation of smart sensors and digital monitoring tools into single-use assemblies is fundamentally altering process analytical technology (PAT). Manufacturers are actively integrating pre-calibrated, disposable sensors for essential parameters like pH and dissolved oxygen directly into consumable bags and tubing, allowing for real-time data collection without endangering system sterility. This move toward digitalization enables stricter process control and aids the industry's shift toward automated, data-centric bioprocessing workflows. The commercial success of these advanced monitoring solutions is strong; according to Repligen Corporation, February 2025, in the 'Fourth Quarter and Full Year 2024 Financial Results', the company stated that total orders exceeded sales by 6% during the quarter, a performance specifically attributed to the heightened demand for its Analytics and Filtration franchises.
Report Scope
In this report, the Global Single Use Consumables Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Single Use Consumables Market.
Global Single Use Consumables Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: